Boao Lecheng pilot zone (Hainan, China): what the zone rules allow
Designated hospitals in the zone may use certain imported medicines and devices not yet approved in China, case by case. Since 1 May 2026 a national regulation on new biomedical technologies runs in parallel. This is not blanket access to experimental treatments.
What this page covers. Rules and their official sources only, not whether a treatment works.
What the official sources say
- The State Council approved establishing the Hainan pilot zone on 28 February 2013. Four national agencies issued its development implementation plan on 16 September 2019. source
- The State Council authorised Hainan to approve imports of certain urgently needed devices unavailable through China’s ordinary market, for use at designated hospitals inside the pilot zone. source
- Hainan rules cover urgent clinical imports of both drugs and devices. They cite State Council decisions Guo Fa [2018] No. 10 and No. 43, plus the 2019 implementation plan. source
- Hainan adopted a zone-specific regulation promoting new biomedical technologies on 29 November 2024, effective 1 February 2025. source
- The Boao Lecheng Medical Products Administration exercises designated local health and medical-product regulatory functions under the zone oversight measures. source
- An official approval names Boao Super Hospital general surgery and urology among the departments allowed to use specified urgently needed imported medicines and devices. source
- The zone regulator approved professional registration of Boao Lecheng Research Hospital as a medical institution in March 2026. source
- China’s national New Biomedical Technologies clinical research and application regulation took effect on 1 May 2026 and establishes a national framework in parallel with the previously documented Hainan pilot. source